Literature DB >> 27401580

Impact of Infectious Diseases Consultation on Clinical Outcomes of Patients with Staphylococcus aureus Bacteremia in a Community Health System.

R Brigg Turner1, Elena Valcarlos2, Regina Won3, Eric Chang3, Jacqueline Schwartz4.   

Abstract

Staphylococcus aureus bacteremia (SAB) causes high rates of morbidity and death. Several studies in academic health settings have demonstrated that consultations from infectious diseases specialists improve the quality of care and clinical outcomes for SAB. Few data that describe the impact in resource-limited settings such as community hospitals are available. This retrospective cohort study evaluated the adherence to quality-of-care indicators and the clinical outcomes for SAB in a five-hospital community health system (range of 95 to 272 available beds per hospital), for patients with versus without infectious diseases consultation (IDC). IDC was provided if requested by the attending physician. The primary outcome was the incidence of treatment failure, defined as 30-day in-hospital death or 90-day SAB recurrence. Other outcomes included adherence to quality-of-care indicators. A total of 473 adult patients with SAB were included, with 369 (78%) receiving IDC. We identified substantial differences in baseline characteristics between the IDC group and the no-IDC group, including greater incidences of complicated bacteremia and intravenous drug users in the IDC group, with similar rates of severe illness (measured by Pitt bacteremia scores). Adherence to quality-of-care indicators was greater for patients with IDC (P < 0.001). After adjustment for other predicting variables, IDC was associated with a lower rate of treatment failure (adjusted odds ratio, 0.42 [95% confidence interval, 0.20 to 0.86]; P = 0.018). IDC provided better quality of care and better clinical outcomes for patients with SAB who were treated at small, resource-limited, community hospitals.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27401580      PMCID: PMC5038301          DOI: 10.1128/AAC.00439-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Hospital volume is related to clinical and economic outcomes of esophageal resection in Maryland.

Authors:  J B Dimick; S M Cattaneo; P A Lipsett; P J Pronovost; R F Heitmiller
Journal:  Ann Thorac Surg       Date:  2001-08       Impact factor: 4.330

2.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

3.  Hospital volume and 30-day mortality for three common medical conditions.

Authors:  Joseph S Ross; Sharon-Lise T Normand; Yun Wang; Dennis T Ko; Jersey Chen; Elizabeth E Drye; Patricia S Keenan; Judith H Lichtman; Héctor Bueno; Geoffrey C Schreiner; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

Review 4.  Blood culture contamination: persisting problems and partial progress.

Authors:  Melvin P Weinstein
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

5.  Infectious diseases consultation and the management of Staphylococcus aureus bacteremia.

Authors:  Brittany L Fries; Carmelo Licitra; Antonio Crespo; Kauser Akhter; Mary T Busowski; Diana Salazar; Mark R Wallace
Journal:  Clin Infect Dis       Date:  2013-11-07       Impact factor: 9.079

6.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-01-04       Impact factor: 9.079

Review 7.  Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary.

Authors:  J W Chow; V L Yu
Journal:  Int J Antimicrob Agents       Date:  1999-01       Impact factor: 5.283

8.  The value of infectious diseases consultation in Staphylococcus aureus bacteremia.

Authors:  Hitoshi Honda; Melissa J Krauss; Jeffrey C Jones; Margaret A Olsen; David K Warren
Journal:  Am J Med       Date:  2010-05-20       Impact factor: 4.965

9.  Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital.

Authors:  Johannes P Borde; Nadide Batin; Siegbert Rieg; Rüdiger Feik; Christian Reimling; Winfried V Kern; Katja de With; Johannes Hübner; Michaela Ruhnke; Klaus Kaier
Journal:  Infection       Date:  2014-06-03       Impact factor: 3.553

Review 10.  Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.

Authors:  Rinaldo Bellomo; Claudio Ronco; John A Kellum; Ravindra L Mehta; Paul Palevsky
Journal:  Crit Care       Date:  2004-05-24       Impact factor: 9.097

View more
  8 in total

1.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

Review 2.  Antimicrobial Treatment Duration in Sepsis and Serious Infections.

Authors:  Lindsay M Busch; Sameer S Kadri
Journal:  J Infect Dis       Date:  2020-07-21       Impact factor: 5.226

3.  Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections.

Authors:  Jason P Burnham; Margaret A Olsen; Dustin Stwalley; Jennie H Kwon; Hilary M Babcock; Marin H Kollef
Journal:  Open Forum Infect Dis       Date:  2018-03-15       Impact factor: 3.835

4.  Individual variation is the key to the development of a vaccine against Staphylococcus aureus: a comparative study between mice lineages.

Authors:  D P Dos Santos; I P R Muniz; A F Queiroz; I S Pereira; M P A Souza; L J Lima; L R O Sousa; I S Ribeiro; M P L Galantini; L M Marques; T B Figueiredo; R A A da Silva
Journal:  Braz J Med Biol Res       Date:  2018-03-26       Impact factor: 2.590

5.  Current Status and Survival Impact of Infectious Disease Consultation for Multidrug-Resistant Bacteremia in Ventilated Patients: A Single-Center Experience in Korea.

Authors:  Insu Kim; Won-Young Kim; Eun Suk Jeoung; Kwangha Lee
Journal:  Acute Crit Care       Date:  2018-04-26

6.  Development of quality indicators for the management of Staphylococcus aureus bacteraemia.

Authors:  Jaap Ten Oever; Joëll L Jansen; Thomas W van der Vaart; Jeroen A Schouten; Marlies E J L Hulscher; Annelies Verbon
Journal:  J Antimicrob Chemother       Date:  2019-11-01       Impact factor: 5.790

7.  Opportunities for antibiotic optimisation and outcome improvement in patients with negative blood cultures: study protocol for a cluster-randomised crossover trial, the NO-BACT study.

Authors:  Silvia Jiménez-Jorge; Zaira R Palacios-Baena; Clara M Rosso-Fernández; José A Girón-Ortega; Jesús Rodriguez-Baño; Pilar Retamar
Journal:  BMJ Open       Date:  2019-12-18       Impact factor: 2.692

8.  Assessing the impact of a 'bundle of care' approach to Staphylococcus aureus bacteraemia in a tertiary hospital.

Authors:  Jared Green; Julia Howard; Avinesh Shankar; Richard Clinghan; Tessa Luff; Mark Birch; Alan Pithie; Anja Werno; Sarah Metcalf; Stephen Chambers
Journal:  Infect Prev Pract       Date:  2020-09-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.